LLY
CALLS ▲Eli Lilly and Company
$1417.54
+3.19%delayed
News – · Trend ▲ · above call trigger ▲
Expected move (1d)
▼ $1372.63to$1462.45 ▲
ATR ±$44.91 (+3.17%)Implied ±$56.03 (+3.95%)
Entry Reference
Price / prev close$1417.54 / $1373.70
Day range$1409.00 – $1449.68
52-wk range$834.19 – $1449.68(95%)
Volume vs avg1.97×
ATR (14d)$44.91
MA 8 / 21$1311.44 / $1241.10
MA 50 / 200$1197.14 / $1091.24
Call ▲ / Put ▼ trigger$1384.30 / $1363.10
+1 / +2 ATR$1462.45 / $1507.37
-1 / -2 ATR$1372.63 / $1327.71
Support: 1292.65 1249.45 1232.00
Resistance: -
Near-the-money contracts
exp 2026-11-06Calls
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 1390 | $42.85 | 41% | 0.66 | -2.32 | 61 |
| 1400 | $36.17 | 39% | 0.61 | -2.29 | 279 |
| 1410 | $29.48 | 39% | 0.56 | -2.35 | 64 |
| 1415 | $27.35 | 38% | 0.53 | -2.32 | 38 |
| 1420 | $25.88 | 39% | 0.50 | -2.40 | 178 |
| 1440 | $15.47 | 37% | 0.39 | -2.13 | 63 |
Puts
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 1360 | $9.32 | 43% | -0.22 | -1.81 | 15 |
| 1380 | $13.30 | 40% | -0.29 | -1.96 | 19 |
| 1400 | $20.95 | 41% | -0.39 | -2.24 | 13 |
| 1420 | $30.15 | 41% | -0.50 | -2.32 | 5 |
| 1440 | $41.35 | 42% | -0.59 | -2.30 | 2 |
| 1480 | $71.30 | 48% | -0.74 | -2.18 | 1 |
Δ = delta (≈ probability ITM), θ/day = daily time decay, IV = implied vol. Greeks computed via Black-Scholes from Yahoo IV.
Recent news
- Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q32h ago
- What Eli Lilly and Company (LLY) Said on Its Q3 Earnings Call8h ago
- Novo Nordisk (NYSE:NVO) Could Be 61% Undervalued Following Rising GLP 1 Competition9h ago
- OmniAb, Inc. Q3 2026 Earnings Call Summary10h ago
- LLY, ABBV Stocks Hit All-Time High – Here’s What’s Driving Investor Enthusiasm Today12h ago
- Eli Lilly Is Now Worth as Much as Warren Buffett's Berkshire Hathaway. Can the Rally Keep Going?13h ago
- Amazon earnings fall short amid tech sell-off, and Anthropic becomes SpaceX's top partner14h ago
- Eli Lilly’s Next Trillion-Dollar Opportunity May Go Beyond Weight-Loss Drugs14h ago
- Stock Market: Google, Amazon, Intel, ServiceNow Trigger Tech Wreck, But Other Sectors Solid: Weekly Review14h ago
- Walmart & Eli Lilly join the pushback against blockchain-based stock trading15h ago
- Eli Lilly raises earnings outlook as obesity drug demand drives strong growth, UBS says15h ago
- Binance hacked, and withdrawals are now on hold, plus Nasdaq wants tokenization on its own terms16h ago
Reference data only. Not a recommendation. Greeks and expected-move figures are estimates, not certainties. You confirm all entries and contracts in TradingView and Charles Schwab.